400 Park Office Drive, Suite 113

Research Triangle Park, NC 27709 

© 2019 by Sapere Bio.  All rights reserved.

Biomarkers of senescence and physiologic reserve

Biomarkers of senescence drive risk prediction for AKI

Clinical variables

Two clinical variables strengthen the predictive ability of the biomarkers

AKI-Sapere's predictive ability is driven by senescence biomarkers and strengthened by several clinical variables.  In Sapere Bio's discovery study at Duke and Johns Hopkins, common renal biomarkers (sCysC, KIM-1, TIMP-2, L-FABP1, albumin, B2M, NGAL, OPN, UMOD) did not predict AKI before surgery and are therefore not included in AKI-Sapere.